Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations

Pal SK;Rosenberg JE;Hoffman-Censits JH;Berger R;Quinn DI;Galsky MD;Wolf J;Dittrich C;Keam B;Delord JP;Schellens JHM;Gravis G;Medioni J;Maroto P;Sriuranpong V;Charoentum C;Burris HA;Grünwald V;Petrylak D;Vaishampayan U;Gez E;De Giorgi U;Lee JL;Voortman J;Gupta S;Sharma S;Mortazavi A;Vaughn DJ;Isaacs R;Parker K;Chen X;Yu K;Porter D;Graus Porta D;Bajorin DF.

2018-01-01